MILAN and NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and in cell-based therapeutics, is pleased to announce that Pierluigi Paracchi, CEO, will attend as a speaker to the Italy-U.S.
meeting “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective” scheduled at 2.00 PM on October 25 th , 2024 at the U.S.
Senate - Washington, D.C. The event is organized by the U.
S. National Security Commission on Emerging Biotechnology (NSCEB) and the Italian Embassy in the U.S .
The upcoming mission to Washington, D.C. is part of the strategic plan of the Italian Working Group on the Internationalization of the Biotech Sector (NWTIB) established by the Deputy Prime Minister and Minister of Foreign Affairs Antonio Tajani.
Pierluigi Paracchi, as a moderator of the NWTIB, will present the recently released Interim Report (full report in English HERE ). Keynote Speakers: Michelle Rozo , Vice Chair of the National Security Commission on Emerging Biotechnology (NSCEB) Mariangela Zappia , Ambassador of Italy to the U.S.
Megan Frisk , Ph.D., Director Division of lnternational Affairs at the Advanced Research Projects Agency for Health (ARPA-H) Mauro Battocchi , Director General for the Promotion of ltaly at the ltalian Ministry of Foreign Affairs Pierluigi Paracchi , CEO and Co-founder of Genenta Science (Nasdaq: GNTA) Patrick Soon-Shiong , M.
D., Chairman of Chan Soon-Shiong Family Foundation, Exe.
